Dalvastatin

This classification denotes an anti-lipidemic agent with the molecular formula C24H31FO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZWE0X0IG9D, chemically known as 2h-pyran-2-one, tetrahydro-6-(2-(2-(4-fluoro-3-methylphenyl)-4,4,6,6-tetramethyl-1-cyclohexen-1-yl)ethenyl)-4-hydroxy-, (4r-(4-alpha,6-beta(e)))- but generally known as dalvastatin, which bears US NIH Compound Identifier 6436001. European Medicines Agency schedules Dalvastatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06894MIG. The term DALVASTATIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). DALVASTATIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, DALVASTATIN remains the US FDA Preferred Term for this commodity. Dalvastatin bears US NLM identifiers UMLS ID C0165939 and NCI Concept Code C75254. SMILES: Fc1c(cc(C2=C(C(CC(C2)(C)C)(C)C)/C=C/C2OC(=O)CC(O)C2)cc1)C.